cagrilintide/semaglutide CagriSema (Cagrilintide–Semaglutide) in Adults with Overweight or Obesity and Type 2 Diabetes ADA: Once-Weekly Cagrilintide + Semaglutide

Supplementation in plant-based athletes produced more pronounced performance and energy gains in a 2019 Journal of Nutrition study than in meat-eaters at the same dose

GLP-1 therapy isnt recommended for teens with certain medical conditions such as a personal or family history of medullary thyroid cancer or MEN2, pancreatitis, severe gastrointestinal issues (like gastroparesis or IBD flare), current or planned pregnancy, or active eating or psychiatric disorders

Its not either/or, and anyone who tells you a peptide replaces the fundamentals is selling you something

Lifestyle is drastically improved now compared to prior to GLP1 treatment